Angiogenesis and the tumor space-time continuum

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 16, 2012, Pages

  Nugue, Guillaume ^a   Wion, Didier ^a  

^a GRENOBLE INSTITUT DES NEUROSCIENCES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR;

ANGIOGENESIS; CANCER CELL; CANCER GROWTH; CANCER STEM CELL; CELL POPULATION; CELL PROLIFERATION; CELL RENEWAL; HYPOXIA; LETTER; NEOVASCULARIZATION (PATHOLOGY); PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; TUMOR GROWTH;

ANGIOGENESIS INHIBITORS; ANIMALS; BREAST NEOPLASMS; FEMALE; HUMANS; NEOPLASTIC STEM CELLS;

EID: 84859935499     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1203154109     Document Type: Letter

References (5)

1. Conley SJ, et al. (2012) Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia. Proc Natl Acad Sci USA 109:2784-2789.
2. Mathieu J, et al. (2011) HIF induces human embryonic stem cell markers in cancer cells. Cancer Res 71:4640-4652.
3. Qiang L, et al. (2012) HIF-1α is critical for hypoxia-mediated maintenance of glioblastoma stem cells by activating Notch signaling pathway. Cell Death Differ 19:284-294.
4. Pàez-Ribes M, et al. (2009) Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 15:220-231.
5. Folkman J (1971) Tumor angiogenesis: therapeutic implications. N Engl J Med 285:1182-1186.